MACRA Tidbit for the Week: CMS Releases CY 2017 MIPS Participation Data Impacting 2019 Medicare Payments

ACG’s very first “MACRA Tidbit for the Week” discussed the potential problems with MIPS and whether there was actually an opportunity to receive the bonuses as marketed by the Centers for Medicare and Medicaid Services (CMS) and policymakers.  ...

Trump Administration Seeking to Lower Costs for Medicare Part B Drugs

On Thursday, CMS announced a pre-regulation (“Advance Notice of Proposed Rulemaking”) seeking input on a new “International Pricing Index” (IPI) payment model related to the costs of drugs administered in physician practices and hospitals.  ...

New CMS Rule: Drug Advertisements Must Include List Prices

On Monday, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule requiring drug manufacturers to list a product’s monthly wholesale price, or the cost for a typical course of treatment, if it is greater than $35 ...

ACG Working on Stark Law Reform: We Need Your Help!

On June 25, 2018, the Centers for Medicare and Medicaid Services (CMS) published a formal request for information, seeking comment from ACG members and other stakeholders on how to better promote value-based payments.  Specifically, CMS is ...

Medicare Trustees Report Released: why is this important for ACG members?

Whitfield L. Knapple, MD, FACGChair, Legislative and Public Policy Council On Tuesday, the 2018 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds was released, with ...

2 Important CMS Updates for GI Practices: Biosimilar Changes and Medicare Appeals Guidance

Medicare Part B Biosimilar Payment and Required New Codes: Dates of Service on or after April 1, 2018 Pursuant to a recent CMS update, the “Quarterly Healthcare Common Procedure Coding System (HCPCS) Drug/Biological Code Changes – April ...